Luminex Corp. (LMNX)

21.85
0.32 1.44
NASDAQ : Health Technology
Prev Close 22.17
Open 22.24
Day Low/High 21.68 / 22.24
52 Wk Low/High 18.44 / 22.59
Volume 200.69K
Avg Volume 250.70K
Exchange NASDAQ
Shares Outstanding 44.43M
Market Cap 985.04M
EPS 0.70
P/E Ratio 41.83
Div & Yield 0.24 (1.08%)

Latest News

Luminex is Now Oversold (LMNX)

Luminex is Now Oversold (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

LMNX Makes Notable Cross Below Critical Moving Average

LMNX Makes Notable Cross Below Critical Moving Average

In trading on Tuesday, shares of Luminex Corp crossed below their 200 day moving average of $20.36, changing hands as low as $20.28 per share. Luminex Corp shares are currently trading down about 0.7% on the day.

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ex-Dividend Reminder: Luminex, DCT Industrial Trust and CYS Investments

Ex-Dividend Reminder: Luminex, DCT Industrial Trust and CYS Investments

Looking at the universe of stocks we cover at Dividend Channel, on 12/21/17, Luminex Corp , DCT Industrial Trust Inc , and CYS Investments, Inc. will all trade ex-dividend for their respective upcoming dividends.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DLHC, ERI, FARM, GLRE, HCLP, HFC, HRZN, LMNX, WEX, ZAGG Downgrades: BDC, CWCO, HRTG, TLGT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Luminex Corporation Receives FDA Clearance For ARIES Group A Strep Assay

Luminex Corporation Receives FDA Clearance For ARIES Group A Strep Assay

Expands Portfolio of IVD Respiratory Tests on the ARIES Systems

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.09/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Luminex Reaches Analyst Target Price

Luminex Reaches Analyst Target Price

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.02/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Oversold Conditions For Luminex (LMNX)

Oversold Conditions For Luminex (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Luminex Reaches Analyst Target Price

Luminex Reaches Analyst Target Price

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.31/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AAV, ARCC, BID, CFG, ENSG, EXEL, GCAP, HAE, HMLP, LGND, MOMO, MTW, PBR, RYI Downgrades: AEUA, ATSG, ATW, LMNX, MOH, MSB, NBEV, PAGP, SAVE, TIS Initiations: MCRB, TWLO Read on to get TheStreet Quant Ratings' detailed report:

Luminex Breaks Below 200-Day Moving Average - Notable for LMNX

Luminex Breaks Below 200-Day Moving Average - Notable for LMNX

In trading on Friday, shares of Luminex Corp crossed below their 200 day moving average of $19.90, changing hands as low as $19.80 per share. Luminex Corp shares are currently trading down about 1.4% on the day.

YieldBoost Luminex Corp To 8.8% Using Options

Shareholders of Luminex Corp looking to boost their income beyond the stock's 1.2% annualized dividend yield can sell the January 2018 covered call at the $22.50 strike and collect the premium based on the 95 cents bid, which annualizes to an additional 7.7% rate of return against the current stock price (at Stock Options Channel we call this the YieldBoost), for a total of 8.8% annualized rate in the scenario where the stock is not called away. Any upside above $22.50 would be lost if the stock rises there and is called away, but LMNX shares would have to climb 9.2% from current levels for that to happen, meaning that in the scenario where the stock is called, the shareholder has earned a 13.8% return from this trading level, in addition to any dividends collected before the stock was called.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BKFS, CWAY, DE, EZPW, GSK, LMNX Downgrades: AMC, ESRT, MYOK, WERN Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $19.25, changing hands for $20.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Biotech Movers: Luminex, Exelixis, AMAG Pharmaceuticals

Biotech Movers: Luminex, Exelixis, AMAG Pharmaceuticals

Luminex, Exelixis, AMAG Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.

Analysts' Actions -- Kimberly-Clark, IberiaBank, Ionis Pharma, Actuant and More

Analysts' Actions -- Kimberly-Clark, IberiaBank, Ionis Pharma, Actuant and More

Here are Friday's top research calls, including upgrades for IberiaBank and Actuant, and downgrades for Kimberly-Clark and Ionis Pharma.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABT, HIHO, KE, LBRDA, SSP, TLRD, VIV Downgrades: CORE, LMNX, PKOH, SIM, TATT, TTEC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Toll Brothers and Luminex Initiate Dividends

In each case, the start of cash payouts follows better-than-expected quarterly results.

Relative Strength Alert For Luminex

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

LMNX: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/13/2017 settlement date, and Luminex Corp is one of the most shorted stocks of the Russell 3000, based on 11.24 "days to cover" versus the median component at 5.04. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

LMNX: Insiders vs. Shorts

LMNX: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/14/2016 settlement date, and Luminex Corp is one of the most shorted stocks of the Russell 3000, based on 16.32 "days to cover" versus the median component at 6.24. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Oversold Conditions For Luminex (LMNX)

Oversold Conditions For Luminex (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $21.67, changing hands for $21.95/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

TheStreet Quant Rating: B- (Buy)